SCHEMBL20109301

SCHEMBL20109301

C[C@@H](O)CNC(=S)Nc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
MAPT P10636 3/20 0.59
ALOX12 P18054 3/20 0.59
LMNA P02545 2/20 0.59
KMT2A Q03164 2/20 0.59
MAOA P21397 2/20 0.56
MAOB P27338 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CYP3A4 P08684 1/20 0.55
TAS2R38 P59533 1/20 0.55
HSD17B10 Q99714 1/20 0.55
ABAT P80404 1/20 0.54
GAA P10253 3/20 0.54
RAB9A P51151 3/20 0.53
NPC1 O15118 2/20 0.53
MEN1 O00255 1/20 0.52
NOX1 Q9Y5S8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31192807 1.00 ALDH1A1 (0.59) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL5450124 0.87 ALDH1A1 (0.74) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL20529633 0.83 SMN1; SMN2 (0.57) ALDH1A1MAPTLMNAKMT2AMAOA
SCHEMBL20529635 0.83 SMN1; SMN2 (0.57) ALDH1A1MAPTLMNAKMT2AMAOA
SCHEMBL20529628 0.83 MAPT (0.65) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL20529629 0.83 MAPT (0.65) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL11830230 0.81 BCL6 (0.57) ALDH1A1MAPTLMNAGAAKDM4E
SCHEMBL11209835 0.81 ALDH1A1 (0.65) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL20529688 0.80 GAA (0.61) ALDH1A1MAPTALOX12LMNAKMT2A
SCHEMBL20529687 0.80 GAA (0.61) ALDH1A1MAPTALOX12LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 ALDH1A1 4621/4885MAPT 4371/4885ALOX12 1819/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 ALDH1A1 4621/4885MAPT 4371/4885ALOX12 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.